These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19618138)

  • 1. [Cost analysis for ambulatory treatment of cystic fibrosis patients in Germany. Overview of the prospective study results].
    Eidt D; Mittendorf T; Wagner TO; Reimann A; Graf von der Schulenburg JM
    Med Klin (Munich); 2009 Jul; 104(7):529-35. PubMed ID: 19618138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resource usage in outpatient care and reimbursement for cystic fibrosis in Germany.
    Eidt-Koch D; Wagner TO; Mittendorf T; Reimann A; von der Schulenburg JM
    Pediatr Pulmonol; 2011 Mar; 46(3):278-85. PubMed ID: 24081887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of illness of cystic fibrosis in Germany: results from a large cystic fibrosis centre.
    Heimeshoff M; Hollmeyer H; Schreyögg J; Tiemann O; Staab D
    Pharmacoeconomics; 2012 Sep; 30(9):763-77. PubMed ID: 22690685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug treatment of cystic fibrosis - cost patterns and savings potential for outpatient treatment].
    Baltin CT; Smaczny C; Wagner TO
    Med Klin (Munich); 2010 Dec; 105(12):887-900. PubMed ID: 21240588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of costs and profits of ambulatory care of Marfan patients after initiation of a novel German legal directive (116 b SGB V)].
    Manow ML; Paulsen N; Rybczynski M; Mir T; Bernhardt AM; Treede H; Ohm G; Fuisting B; Rehder U; Meier F; Vogler M; Meinertz T; Overlack K; von Kodolitsch Y
    Med Klin (Munich); 2010 Aug; 105(8):529-37. PubMed ID: 20824410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom.
    Angelis A; Kanavos P; López-Bastida J; Linertová R; Nicod E; Serrano-Aguilar P;
    BMC Health Serv Res; 2015 Sep; 15():428. PubMed ID: 26416027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cost analysis of contrast-enhanced cranial MRI at a German university hospital].
    Schreyer AG; Friedrich C; Mrosek S; Hoffstetter P; Rennert J; Framme C; Jung EM; Feuerbach S; Schöffski O; Zorger N
    Rofo; 2010 Oct; 182(10):891-9. PubMed ID: 20563960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources.
    Ruof J; Hülsemann JL; Mittendorf T; Handelmann S; von der Schulenburg JM; Zeidler H; Merkesdal S
    Ann Rheum Dis; 2003 Jun; 62(6):544-9. PubMed ID: 12759292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Economic Burden of Cystic Fibrosis in Germany from a Payer Perspective.
    Frey S; Stargardt T; Schneider U; Schreyögg J
    Pharmacoeconomics; 2019 Aug; 37(8):1029-1039. PubMed ID: 30949989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Costs of ulcerative colitis within the German Statutory Health Insurance].
    Prenzler A; Bokemeyer B; Mittendorf T; von der Schulenburg JM
    Dtsch Med Wochenschr; 2010 Feb; 135(7):281-6. PubMed ID: 20146156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France.
    Horvais V; Touzet S; François S; Bourdy S; Bellon G; Colin C; Durieu I
    Int J Technol Assess Health Care; 2006; 22(4):525-31. PubMed ID: 16984688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician-based active cost management of oncological therapies reducing pharmaceutical costs by 83.4% in two years without leaving standard of care.
    Jacobs VR; Thoedtmann J; Euler U; Paepke S; Fischer T; Harbeck N; Kiechle M
    Onkologie; 2005 Aug; 28(8-9):441-5. PubMed ID: 16160408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal trends in healthcare resource use and associated costs of patients with cystic fibrosis.
    Durieu I; Dalon F; Reynaud Q; Lemonnier L; Dehillotte C; Bérard M; Walther D; Viprey M; Van Ganse E; Belhassen M
    J Cyst Fibros; 2022 Jan; 21(1):88-95. PubMed ID: 33865726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe.
    Chevreul K; Michel M; Brigham KB; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Péntek M; von der Schulenburg JM; Kanavos P; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():7-18. PubMed ID: 27059622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cost-of-illness study in patients suffering from atopic eczema in Germany].
    Ehlken B; Möhrenschlager M; Kugland B; Berger K; Quednau K; Ring J
    Hautarzt; 2005 Dec; 56(12):1144-51. PubMed ID: 15933866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Trans-Sectoral Patient Care in Pediatric Oncology: Quality Assurance by Novel Reimbursement Models for Outpatient Services].
    Reinke E; Jürgens H; Haier J; Froehlich B; Kontny U; Rossig C
    Klin Padiatr; 2020 Nov; 232(6):289-293. PubMed ID: 32365390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Costs of ambulatory care for RA patients in Germany].
    Mittendorf T; Merkesdal S; Zeidler H; Graf von der Schulenburg JM; Ruof J
    Med Klin (Munich); 2005 May; 100(5):255-61. PubMed ID: 15902379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cost comparison of hospital and ambulatory i.v. therapy in adult cystic fibrosis patients. Results of a controlled prospective study].
    Krauth C; Busse R; Smaczny C; Ullrich G; Wagner TO; Weber J; Welte T
    Med Klin (Munich); 1999 Oct; 94(10):541-8. PubMed ID: 10554512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic spectrum and treatment requirements of general practice clients. Results of the ADT Panel of the Central Institute of National Health Insurance Management].
    Kerek-Bodden H; Koch H; Brenner G; Flatten G
    Z Arztl Fortbild Qualitatssich; 2000 Jan; 94(1):21-30. PubMed ID: 10721161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nonnative guidelines for allocating human resources in child and adolescent psychiatry using average values under convergence conditions instead of price determination - analysis of the data of university hospitals in Germany concerning the costs of calculating day and minute values according to Psych-PV and PEPP-System].
    Barufka S; Heller M; Prayon V; Fegert JM
    Z Kinder Jugendpsychiatr Psychother; 2015 Nov; 43(6):397-409. PubMed ID: 26602045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.